Leaps by Bayer — Full Portfolio
45 tracked investments · listed companies and verified rows first
Azitra is a clinical-stage biopharmaceutical company developing genetically engineered bacteria and proteins for treating skin diseases through precision dermatology.
AI & Machine LearningBiotechHealthtechFarmington, US
Francisco D. Salva(President and Chief Executive Officer)inAzim Munivar(Executive Officer, Director, Promoter)
BoardStella Robertson(Director)inTravis Whitfill(Executive Officer, Director, Promoter)in
Co-investorsBios PartnersConnecticut InnovationsKdT Ventures
Dewpoint Therapeutics develops condensate-modulating drugs by using an integrated platform that maps, measures, and modulates biomolecular condensates to identify druggable targets and disease mechanisms.
AI & Machine LearningBiotechDeep TechBoston, US
Richard Young, Ph.D.(Director)Anthony Hyman, Ph.D.(Director)Tony Hyman(Scientific Co-founder)Rick Young(Scientific Co-founder)Elisabeth Leiderman(Executive Officer)inAmeet Nathwani, M.D.(Executive Officer, Director)in
Co-investorsARCH Venture PartnersEcoR1 CapitalSamsara BioCapital6 Dimensions CapitalGeneral CatalystInnovation Endeavors+5 more
GRObio (GRO Biosciences) develops protein therapeutics using non-standard amino acids (NSAAs) via its GRO platform, aiming to improve protein potency, stability, and function.
BiotechDeep TechHealthtechCambridge, US
Daniel J Mandell(Chief Executive Officer)Tracey Lodie(Executive Officer)inChristopher Gregg(Director)
BoardMing Fang(Director)Bruce Beutel(Director)Dan Becker(Director)
Co-investorsREDMILEDigitalis VenturesDreamers VCRising TideAtlas VentureInnovation Endeavors+1 more
Indapta Therapeutics develops an off-the-shelf, allogeneic FcRγ-deficient natural killer (g-NK) cell therapy derived from healthy donors to treat cancer and autoimmune diseases.
BiotechHealthtechHouston, US
Guy DiPierro(Chief Operating Officer & Co-Founder)inSungjin Kim(Scientific Founder)John Sunwoo(Scientific Founder)Mark W. Frohlich(Chief Executive Officer)Stefanie Mandl-Cashman(Acting Chief Scientific Officer)
Co-investorsRA CapitalVertex Ventures HC
SonoThera is developing a nonviral, non-invasive gene delivery technology that uses ultrasound and microbubbles (ultrasound-mediated delivery) to deliver genetic payloads to targeted sites in a redosable way.
BiotechDeep TechHealthtechSouth San Francisco, US
Kenneth Greenberg(Co-Founder, President & CEO)in
Co-investorsVida VenturesFoothill VenturesIllumina VenturesMedical Excellence CapitalVivo CapitalARCH Venture Partners+1 more
Soufflé Therapeutics develops nucleic acid medicines that precisely target and deliver genetic therapeutics to specific cell types to treat disease.
AI & Machine LearningBiotechDeep TechWatertown, US
Victor Kotelianski(Founder)Daniel Anderson(Founder and Director)Robert Langer(Founder)Marino Zerial(Founder)Brad Pentelute(Founder)Amir Nashat, ScD(Founder, Director and CEO)
Co-investorsBessemer Venture PartnersSafar PartnersVida VenturesPolaris Partners
65LAB accelerates drug discovery and therapeutic company formation by connecting academic research institutions, life science investors, and Evotec to develop novel medicines into commercial entities.
BiotechDeep TechSingapore, SG
BoardSteve Courtney(Expert in Residence)
Co-investorsLightstone VenturesClavystBio
Ada offers intelligent health technology, including a medical library of doctor-created, research-based information about conditions and symptoms to help people make informed health decisions.
AI & Machine LearningDigital HealthHealthtech
Co-investorsRed River WestSamsung Catalyst FundUrania Ventures10x FoundersBertelsmann InvestmentsMutschler Ventures+1 more
Affini-T Therapeutics develops TCR-based immunotherapies aimed at treating solid tumors, using two complementary therapeutic modalities.
BiotechHealthtechLongevity
Co-investorsAgent CapitalOlive Tree CapitalService Provider CapitalFred Hutchinson Cancer Research CenterHumboldtVida Ventures
BiotechWatertown, US
Kathy Bergsteinsson(Executive Officer)inKathy Yi(Executive Officer)inJoseph Knowles(Executive Officer, Director)
BoardLucio Iannone(Director)inArjun Goyal(Director)Jill DeSimone(Director)
Co-investorsVida Ventures
Andes is a mission-driven company focused on protecting the planet and applying technology in a nature-related context.
AgTechBiotechClimate Tech
Co-investorsAccelr8Capria VenturesCavallo VenturesGermin8 VenturesSunna VenturesVoyager Partners+3 more
Andes develops a microbial technology that converts atmospheric carbon dioxide into stable soil inorganic carbon, enabling agricultural fields to generate verified carbon credits for emissions reductions.
AgTechCleantechClimate TechImpact & Social GoodAlameda, US
Co-investorsCavallo VenturesKdT VenturesVoyager Partners
Apollo Agriculture provides small-scale farmers with farming inputs, financing, insurance, and training to help them run more profitable agribusinesses.
AgTechAI & Machine LearningFintechImpact & Social GoodOakland, US
Earl Joseph St. Sauver(Director)inEli Pollak(CEO)inBenjamin Njenga(CCO & Co-Founder)inEarl St Sauver(Co-Founder)in
BoardSeth Todd Silverman(Director)in
Co-investorsAccionAnthemis VentureCeniarthCommunitas Capital PartnersEndeavor CatalystEquator+6 more
BiotechDavis, US
Steven Watkins(Executive Officer, Director, Promoter)Carlito Lebrilla(Director, Promoter)
Co-investorsArgonautic VenturesiSelect FundAcre Venture PartnersCollaborative FundMitsui & CoMorado Ventures+1 more
Bloom Science is a clinical-stage biotech company developing live biotherapeutic products that replicate the effects of the ketogenic diet through the gut-brain axis.
BiotechDeep TechDigital HealthSan Diego, US
Co-investorsJoyance PartnersPsyMed VenturesSocial StartsApollo Health Ventures
Cavallo Ventures is the venture capital arm of Wilbur-Ellis, investing in innovative technology companies across agriculture, specialty chemicals, and animal nutrition sectors.
AgTechEnterprise Software
Michael Wilbur(President)in
Co-investorsWilbur-Ellis [Cavallo]Accelr8Builders VCCavallo VenturesKdT Ventures
Celea develops deupirfenidone, a pulmonary therapeutic targeting idiopathic pulmonary fibrosis in partnership with physicians and patient advocacy organizations.
BiotechHealthtechMedical Devices
Co-investorsPureTech HealthRA Capital
BiotechGermantown, US
John Mumm(Executive Officer, Director)Vera Mumm(Executive Officer)Pavel Khrimian(Executive Officer, Director)Lucio Iannone(Director)Sally (Yuanheng) Wang(Director)
Co-investorsLumira VenturesPlains VenturesEcho Investment CapitalMPM BioImpact
Dewpoint Innovations develops functional nanostructured polymeric surfaces for atmospheric water capture, technology originating from PhD research at the University of Sydney.
CleantechClimate TechDeep TechNew Materials
Chiara Neto(Founder & Advisor (Chief Scientific Officer))inMing Chiu(Founder & CTO)in
Co-investorsPacific Channel3E Bioventures CapitalARCH Venture PartnersEcoR1 CapitalGeneral CatalystMaverick Ventures+2 more
Edifice Health offers the Inflammatory Age test, a biomarker composite scoring system that measures and monitors a person's inflammatory and immune health for early detection and prevention of chronic disease.
AI & Machine LearningBiotechDigital HealthHealthtechLongevitySan Mateo, US
David Furman, PhD(Co-Founder & Chairman of the Scientific Advisory Board)Mark Davis, PhD(Co-Founder & Scientific Advisory Board Member)inWolfgang Daum(Executive Officer, Director)inDavid Goldberg(CEO)inDavid Furman(Director)
BoardNaveen Krishnan(Director)in
Co-investorsBetter Food VenturesJoyance PartnersPaladin Capital GroupSocial StartsAhren Innovation CapitalVertical Venture Partners
Biotechnology company using multiplex gene editing to develop genetically engineered porcine organs for human transplantation.
BiotechBrookline, US
Luhan Yang(President, Secretary and Treasurer)Geoff MacKay(Chief Executive Officer)
BoardGeorge M. Church(Director)
Co-investorsAlta PartnersARCH Venture PartnersCatalio Capital Management, LPKhosla VenturesOUP (Osage University Partners)b2venture+1 more
Fork & Good develops cultivated meat technology using a hydroponic system approach that integrates cell biology with farming principles to produce real meat from cells at scale.
BiotechDeep TechFoodTechNutley, US
Gabor Forgacs(Chief Scientific Officer and co-founder)inAndras Forgacs(Partner and co-founder)Niya Sharma(Co-founder)Niyati Gupta(Executive Officer, Director)in
BoardLauren Loktev(Director)
Co-investorsAIR CapitalBBG VenturesCollaborative FundMindshift CapitalThe Venture CollectiveStarlight Ventures+1 more
Gandeeva Therapeutics uses AI, machine learning, and atomic-resolution cryo-EM imaging to map druggable protein interactions and design molecular glues that bind at specific protein interfaces.
AI & Machine LearningBiotechDeep TechDigital Health
Sriram Subramaniam(Founder)in
Co-investorsAir Street CapitalLux CapitalObvious VenturesAmgen Ventures
Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.
BiotechDigital HealthMedical DevicesWaltham, US
Amanda Wagner(Executive Officer)Dan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)
BoardLaura Brass(Director)inKai Wucherpfennig(Director)
Co-investorsAgent CapitalDC Investment PartnersLongwood FundMedical Excellence CapitalNovartis Venture FundOno Venture Investment, Inc.+3 more
Khloris Biosciences develops iPSC-based cancer vaccines, using induced pluripotent stem cells to trigger a multi-faceted anti-tumor immune response.
BiotechHealthtechLongevitySouth San Francisco, US
Joseph C. Wu(Director)Lynne A. Bui(Co-Founder, President, CEO, and Chairman of the Board)
Leaf Trade is a B2B marketplace platform connecting cannabis cultivators and dispensaries for wholesale transactions.
AgTechB2B MarketplacesFintechSaaS
Co-investorsArtemis Growth PartnersChingona VenturesHyde Park Angels
MedArrive provides software for scheduling, routing, and real-time tracking of in-home care delivery teams.
HealthtechLogistics & Supply ChainSaaSNew York, US
Inna Plumb(Executive Officer)inDaniel Trigub(Executive Officer, Director)
BoardWilliam Sullivan(Director)Annie Case(Director)inAndy Harrison(Director)Agneta Breitenstein(Director)in
Co-investors7wire VenturesCobalt VenturesCorewell Health VenturesDeclaration PartnersKleiner PerkinsDefine Ventures+2 more
Metagenomi Therapeutics is an in vivo genome editing company that uses genetic material sourced from natural environments (metagenomics) to develop a toolbox of editing tools for deletion, integration, and correction of genetic mutations.
BiotechDeep TechMedical DevicesBerkeley, US
Brian Thomas(Executive Officer, Director, Promoter)in
BoardAndrew Farquharson(Director)inJak Knowles(Director)
Co-investorsCatalio Capital Management, LPRA CapitalSozo VenturesAgent CapitalFrazier Life SciencesHumboldt+5 more
Mozart Therapeutics develops protein therapeutics focused on immunology and oncology treatments.
BiotechMedical Devices
Mark Davis(Scientific Co-Founder)K. Christopher Garcia(Scientific Co-Founder)Calvin Kuo(Scientific Co-Founder)Katie Fanning(President & Chief Executive Officer)in
Co-investorsARCH Venture PartnersJDRF T1D FundMRL Ventures FundOno Venture Investment, Inc.Pfizer Venture InvestmentsSofinnova Partners+4 more
Nava Benefits is a technology-enabled benefits brokerage that pairs benefits consultants with AI-powered tools to help HR teams manage employee health benefits with less administrative work and lower costs.
HealthtechHR TechInsurTech
Brandon Weber(Founder)in
Co-investorsArchetypeAvid VenturesGlynn Capital ManagementHomebrewRA Capital
NewLeaf develops PPFM (Pink-Pigmented Facultative Methylotroph) microbial technologies for agriculture, offering EPA-registered biofungicide and bioinsecticide products (TS601 and TS201) plus crop-specific biostimulants for growers of corn, soy, cotton, rice and other crops.
AgTechBiotechSt. Louis, US
Thomas Laurita(Executive Officer, Director)Michael McFatrich(Executive Officer)Desmond Jimenez(Executive Officer)inStephen Kahn(Executive Officer)Janne Kerovuo(Executive Officer)inDoug Bryant(Executive Officer)
Co-investorsPangaea Ventures Us Inc.S2G InvestmentsSABIC VenturesPangaea Ventures
NextPoint is a precision therapeutics company developing cancer treatments targeting the B7-H7/HHLA2 axis, including a T-cell engager, an antibody-drug conjugate with proprietary linker technology, and a multi-functional checkpoint inhibitor.
BiotechHealthtechAustin, US
Gordon Freeman(Scientific Founder)XingXing Zang(Scientific Founder)inIvan Cheung(Chief Executive Officer)inLeena Gandhi(Chief Medical Officer)inTatiana Novobrantseva(Chief Scientific Officer)inAxel Hoos(Director)
Co-investorsCatalio Capital Management, LPMPM BioImpactSanofi VenturesCatalio Capital ManagementInvusSixty Degree Capital
One.bio develops food products designed to provide beneficial molecular signals to support health and address chronic inflammatory disease.
BiotechFoodTechHealthtechWellness & Fitness
Matt Amicucci(Co-Founder & Chief Science Officer)Matt Barnard(Co-Founder & CEO)in
Co-investorsAcre Venture PartnersAlpha EdisonBetter Ventures Central LlcCollaborative FundDoon CapitalE12 Venture Capital, Llc+4 more
Paratus Sciences is a drug discovery company that uses AI-powered methods to identify first-in-class medicines by studying evolutionary traits, targeting serious diseases where current therapies are inadequate.
AI & Machine LearningBiotechDeep TechUnited States, US
Co-investorsARCH Venture PartnersClavystBioEcoR1 Capital
Iowa City, US
Matthew Beckwith(Executive Officer, Director)Michael Ott(Executive Officer, Director)
Co-investorsFulcrum Global CapitalInnova Memphis, Inc.
SonoThera is developing a nonviral, non-invasive gene delivery technology that uses ultrasound and microbubbles (ultrasound enhancing agents) to deliver genetic payloads to targeted sites in a redosable manner.
BiotechDeep TechDigital Health
Kenneth Greenberg(Founder)in
Co-investorsARCH Venture PartnersSymBiosisUCB VenturesVida VenturesVivo Capital
AgTechEmeryville, US
Eric Davidson(Director)inTravis Bayer(Director)inPaul Beck(Executive Officer)inDave Vosburg(Executive Officer)Adam Litle(Executive Officer, Director)inDerek Norman(Director)in
Co-investorsCavallo VenturesCultivian Sandbox VenturesS2G InvestmentsFall Line CapitalFootPrint CoalitionNorthpond Ventures+2 more
Summer Health provides text-based, on-demand pediatric care that connects parents with doctors within minutes for their children's non-scheduled health needs.
ConsumerDigital HealthHealthtech
Co-investors7wire VenturesCoalition OperatorsCorewell Health VenturesIngeborg InvestmentsLux CapitalSequoia Capital+6 more
Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions to help people navigate the healthcare system and access on-demand care.
AI & Machine LearningDigital HealthHealthtech
Co-investorsAlta PartnersThreshold VenturesAlly Bridge GroupGeneral CatalystGeodesic CapitalHuman Capital+2 more
Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions into a single member experience, helping people navigate the healthcare system and access on-demand care.
AI & Machine LearningDigital HealthHealthtechDenver, US
Glen Tullman(Chief Executive Officer)in
Co-investors7wire VenturesCorewell Health VenturesGeneral CatalystGeodesic CapitalGreatPoint VenturesHuman Capital+5 more
Ukko develops immuno-therapeutics for life-threatening food allergies using a computational protein design platform.
AI & Machine LearningBiotechDigital HealthMountain View, US
Anat Binur(Executive Officer, Director)inYanay Ofran(Director)inJudith Weiss Paltiel(PhD, VP Development)in
BoardScott Brady(Director)Samir Kaul(Director)in
Co-investorsIsrael Biotech FundKhosla VenturesSanara CapitalWestern Technology InvestmentFall Line CapitalPeakBridge VC
Digital health company advancing digestive care.
HealthtechHouston, US
Sally Welborn(Director)William Snyder(Executive Officer, Director)Marco Veremis(Director)inShawn Ellis(Director)inSanford Duncan(Director)Andrew Bouldin(Director)in
Co-investors7wire VenturesBig Pi VenturesFCA Venture PartnersHealth Catalyst CapitalHuman CapitalLifeforce Capital+1 more
Woebot Health builds chat-based AI wellness tools to provide mental health support to individuals and organizations.
AI & Machine LearningDigital HealthMental Health
Alison Darcy(Founder)in
Co-investorsJAZZ Venture PartnersOwl VenturesAI FundNew Enterprise Associates (NEA)Temasek
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
BE BiopharmaCaspian Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.











.png)




































































































































.png)






































